AlphAIAlphAI — Financial news for AI agents
marketscreener.comOCT 51 min read$CB

Morgan Stanley Adjusts Price Target on Chubb to $350 From $360, Keeps Equalweight Rating

Morgan Stanley lowered its price target on Chubb from $360 to $350 while maintaining an Equalweight rating. Chubb's stock is currently at $330.89, with a 5-day change of -0.12% and a year-to-date change of +6.01%.

Original reporting
marketscreener.com
Published Oct 5, 2026, 12:26 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 12:43 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefFinancial news
Primary signal
$CB
Bearish
medium confidence
Mentioned
$CB
Relevance
6/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$CBBearishMed
01

Why it matters

The downgrade may trigger short-term selling but long-term fundamentals unchanged.

02

Market read

Analyst target cuts can move the stock modestly; traders may adjust positions accordingly.

03

What to watch

Underlying earnings and balance sheet strength remain solid; the cut may reflect broader market sentiment.

Relevance 6/10Novelty 6/10Timing: pre‑market today

Background

Morgan Stanley's research team adjusted its valuation assumptions for Chubb, resulting in a lower price target.

Company-level read

Ticker impact

$CBBearishMedium confidence
Context

Morgan Stanley lowered Chubb's price target to $350 from $360.

Expected impact

downward pressure as investors price in the lower target

Evidence & confidence

Target reduction typically leads to short-term sell pressure.

Market effects

Sector

Potentially signals softer outlook for the insurance sector.

Regional

Limited to U.S. markets where Chubb trades.

Global

Minimal global impact beyond insurance peers.

Counterpoint

What could challenge this read

Some investors may view the cut as an overreaction and see buying opportunity.

Key entities

  • Research Firm
    Morgan Stanley

    Issued the price target adjustment.

  • Company
    Chubb Limited

    Subject of the price target change.

Read at source← All news

Related articles

SEP 17
$CBMed

Fed hikes again - an AI-Picked insurer is still cashing in

The Federal Reserve raised rates, impacting markets. Investing.com's AI models show varied portfolio performance. Chubb (CB) is benefiting from higher rates, with a 1.13% monthly gain, due to its Treasury investments. CB's earnings beat estimates, and it trades at a low forward P/E. The Fed's decision is affecting sectors differently.

investing.com2 min
AUG 19
$CBMed

Is Wall Street Bullish or Bearish on Chubb Limited Stock?

Chubb Limited (CB), a global insurer, has seen its stock rise 26% over the past year, outpacing the S&P 500. In 2026, it gained 10.2%, underperforming the index. CB offers a 1.20% dividend yield and has increased payouts for 18 years. Analysts expect 10.7% EPS growth this year. The consensus rating is 'Moderate Buy' with a mean price target of $369.36, suggesting 6.1% upside.

yahoo.com2 min
JUL 26
$CBMed

What Chubb (CB)'s Earnings Beat and Completed Buyback Mean For Shareholders

Chubb Limited (CB) reported Q2 2026 earnings above analyst estimates, citing higher underwriting and investment income and 3.6% net premium written growth across Property & Casualty and Life. The company also completed a US$4.45 billion multi-year buyback totaling 14,811,112 shares. Chubb Tempest Re named James Wixtead Executive Chairman and Michael O’Donnell President.

simplywall.st5 min